A detailed history of Prudential PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prudential PLC holds 164,500 shares of ABBV stock, worth $27.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
164,500
Previous 161,336 1.96%
Holding current value
$27.6 Million
Previous $27.7 Million 17.39%
% of portfolio
0.17%
Previous 0.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $518,389 - $630,680
3,164 Added 1.96%
164,500 $32.5 Million
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $2.33 Million - $2.72 Million
15,051 Added 10.29%
161,336 $27.7 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $11.8 Million - $13.5 Million
-73,939 Reduced 33.57%
146,285 $26.6 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $1.5 Million - $1.69 Million
10,933 Added 5.22%
220,224 $34.1 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $3.45 Million - $4 Million
25,858 Added 14.1%
209,291 $31.2 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $978,983 - $1.22 Million
-7,388 Reduced 3.87%
183,433 $24.7 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $427,033 - $491,792
-2,953 Reduced 1.52%
190,821 $30.4 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $5.18 Million - $6.21 Million
37,446 Added 23.95%
193,774 $31.3 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $6.64 Million - $7.62 Million
49,498 Added 46.33%
156,328 $21 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $3.68 Million - $4.67 Million
26,714 Added 33.34%
106,830 $16.4 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $1.1 Million - $1.36 Million
8,330 Added 11.6%
80,116 $13 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $424,241 - $536,787
-3,949 Reduced 5.21%
71,786 $9.72 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $17.5 Million - $19.9 Million
-164,738 Reduced 68.51%
75,735 $8.17 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $70 Million - $78 Million
-665,297 Reduced 73.45%
240,473 $27.1 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $45.7 Million - $50.3 Million
-446,578 Reduced 33.02%
905,770 $98 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $43.7 Million - $59 Million
-543,381 Reduced 28.66%
1,352,348 $145 Million
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $39.8 Million - $46.7 Million
-463,591 Reduced 19.65%
1,895,729 $166 Million
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $10.5 Million - $14.1 Million
143,770 Added 6.49%
2,359,320 $232 Million
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $36.2 Million - $54.9 Million
561,839 Added 33.97%
2,215,550 $169 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $17 Million - $21.3 Million
-236,096 Reduced 12.49%
1,653,711 $146 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $22.6 Million - $27.2 Million
-359,255 Reduced 15.97%
1,889,807 $143 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $4.49 Million - $5.74 Million
-68,307 Reduced 2.95%
2,249,062 $164 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $5.33 Million - $6.27 Million
69,098 Added 3.07%
2,317,369 $187 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $11.8 Million - $14.5 Million
-151,373 Reduced 6.31%
2,248,271 $207 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $25.4 Million - $28.2 Million
-285,626 Reduced 10.64%
2,399,644 $227 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $23.7 Million - $28 Million
263,488 Added 10.88%
2,685,270 $249 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $26.3 Million - $35.2 Million
-285,633 Reduced 10.55%
2,421,782 $229 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $170 Million - $187 Million
-1,903,018 Reduced 41.28%
2,707,415 $262 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $130 Million - $166 Million
-1,860,682 Reduced 28.75%
4,610,433 $410 Million
Q2 2017

Aug 14, 2017

BUY
N/A
6,471,115
6,471,115 $469 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.